Oligonucleotide Synthesis Market Size, Share, Industry Trends and Forecast to 2030

Oligonucleotide Synthesis Market Size & CAGR in 2021

The global oligonucleotide synthesis market is estimated to have a growth rate of 5.2% CAGR from 2021 to 2026. The market size is expected to reach USD 3.5 billion by 2026, growing from USD 2.5 billion in 2021.

COVID-19 Impact on the Oligonucleotide Synthesis Market

The COVID-19 pandemic has had a significant impact on the oligonucleotide synthesis market. Due to disruptions in the global supply chain and manufacturing processes, the market witnessed a slight decline in growth during the initial phases of the pandemic. However, with the increasing focus on research and development of COVID-19 therapeutics and diagnostics, the demand for oligonucleotide synthesis services has surged.

Oligonucleotide Synthesis Dynamics

Oligonucleotide synthesis is a crucial process in biotechnology and pharmaceutical research, as it involves the production of custom-designed DNA or RNA sequences. The growing demand for personalized medicine, gene therapy, and molecular diagnostics has propelled the growth of the oligonucleotide synthesis market. Advancements in nucleotide chemistry, automation, and high-throughput technologies have further enhanced the efficiency and accuracy of oligonucleotide synthesis.

Segments and Related Analysis

By Product Type:

- Custom Oligonucleotides

- Predesigned Oligonucleotides

- Others

By Application:

- Research

- Diagnostics

- Therapeutics

By End-User:

- Biopharmaceutical Companies

- Academic & Research Institutes

- Contract Research Organizations

By Region Analysis

North America

- The North American oligonucleotide synthesis market is expected to lead globally due to the presence of key market players, technological advancements, and increasing investments in research and development.

Europe

- Europe is anticipated to witness significant growth in the oligonucleotide synthesis market, driven by the rising adoption of precision medicine and genetic testing.

Asia Pacific

- The Asia Pacific region is projected to register the highest CAGR in the oligonucleotide synthesis market, attributed to the growing biopharmaceutical industry, government initiatives supporting genomics research, and increasing healthcare expenditure.

Key Market Players and Competitive Landscape

Some of the key players in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Eurofins Scientific, Integrated DNA Technologies, Inc., Merck KGaA, and Agilent Technologies, among others. These companies are focusing on strategic collaborations, product launches, and acquisitions to strengthen their market position and expand their product portfolios.

Recent Happenings in the Oligonucleotide Synthesis Market

- In January 2021, Eurofins Genomics announced the launch of its next-generation sequencing (NGS) services for oligonucleotide synthesis, providing researchers with advanced solutions for genomics research.

- In March 2021, Thermo Fisher Scientific Inc. acquired Phitonex, Inc., a developer of advanced fluorescent dyes for high-resolution flow cytometry, with the aim to enhance its fluorescence capabilities in oligonucleotide synthesis.

- In September 2021, Integrated DNA Technologies, Inc. collaborated with Twist Bioscience Corporation to expand their product offerings in custom DNA synthesis and genomics research, strengthening their market presence in the oligonucleotide synthesis segment.